Global Primary Biliary Cirrhosis Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Primary Biliary Cirrhosis Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Primary Biliary Cirrhosis Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Primary Biliary Cirrhosis Drug by Country/Region, 2017, 2022 & 2028

2.2 Primary Biliary Cirrhosis Drug Segment by Type

2.2.1 Budesonide

2.2.2 FFP-104

2.2.3 GSK-2330672

2.2.4 MBX-8025

2.2.5 NGM-282

2.2.6 Others

2.3 Primary Biliary Cirrhosis Drug Sales by Type

2.3.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Primary Biliary Cirrhosis Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Primary Biliary Cirrhosis Drug Sale Price by Type (2017-2022)

2.4 Primary Biliary Cirrhosis Drug Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Primary Biliary Cirrhosis Drug Sales by Application

2.5.1 Global Primary Biliary Cirrhosis Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Primary Biliary Cirrhosis Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Primary Biliary Cirrhosis Drug Sale Price by Application (2017-2022)

3 Global Primary Biliary Cirrhosis Drug by Company

3.1 Global Primary Biliary Cirrhosis Drug Breakdown Data by Company

3.1.1 Global Primary Biliary Cirrhosis Drug Annual Sales by Company (2020-2022)

3.1.2 Global Primary Biliary Cirrhosis Drug Sales Market Share by Company (2020-2022)

3.2 Global Primary Biliary Cirrhosis Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Primary Biliary Cirrhosis Drug Revenue by Company (2020-2022)

3.2.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2020-2022)

3.3 Global Primary Biliary Cirrhosis Drug Sale Price by Company

3.4 Key Manufacturers Primary Biliary Cirrhosis Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Primary Biliary Cirrhosis Drug Product Location Distribution

3.4.2 Players Primary Biliary Cirrhosis Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Primary Biliary Cirrhosis Drug by Geographic Region

4.1 World Historic Primary Biliary Cirrhosis Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Primary Biliary Cirrhosis Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Primary Biliary Cirrhosis Drug Annual Revenue by Geographic Region

4.2 World Historic Primary Biliary Cirrhosis Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Primary Biliary Cirrhosis Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Primary Biliary Cirrhosis Drug Annual Revenue by Country/Region

4.3 Americas Primary Biliary Cirrhosis Drug Sales Growth

4.4 APAC Primary Biliary Cirrhosis Drug Sales Growth

4.5 Europe Primary Biliary Cirrhosis Drug Sales Growth

4.6 Middle East & Africa Primary Biliary Cirrhosis Drug Sales Growth

5 Americas

5.1 Americas Primary Biliary Cirrhosis Drug Sales by Country

5.1.1 Americas Primary Biliary Cirrhosis Drug Sales by Country (2017-2022)

5.1.2 Americas Primary Biliary Cirrhosis Drug Revenue by Country (2017-2022)

5.2 Americas Primary Biliary Cirrhosis Drug Sales by Type

5.3 Americas Primary Biliary Cirrhosis Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Primary Biliary Cirrhosis Drug Sales by Region

6.1.1 APAC Primary Biliary Cirrhosis Drug Sales by Region (2017-2022)

6.1.2 APAC Primary Biliary Cirrhosis Drug Revenue by Region (2017-2022)

6.2 APAC Primary Biliary Cirrhosis Drug Sales by Type

6.3 APAC Primary Biliary Cirrhosis Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Primary Biliary Cirrhosis Drug by Country

7.1.1 Europe Primary Biliary Cirrhosis Drug Sales by Country (2017-2022)

7.1.2 Europe Primary Biliary Cirrhosis Drug Revenue by Country (2017-2022)

7.2 Europe Primary Biliary Cirrhosis Drug Sales by Type

7.3 Europe Primary Biliary Cirrhosis Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Primary Biliary Cirrhosis Drug by Country

8.1.1 Middle East & Africa Primary Biliary Cirrhosis Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Primary Biliary Cirrhosis Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Primary Biliary Cirrhosis Drug Sales by Type

8.3 Middle East & Africa Primary Biliary Cirrhosis Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug

10.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

10.4 Industry Chain Structure of Primary Biliary Cirrhosis Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Primary Biliary Cirrhosis Drug Distributors

11.3 Primary Biliary Cirrhosis Drug Customer

12 World Forecast Review for Primary Biliary Cirrhosis Drug by Geographic Region

12.1 Global Primary Biliary Cirrhosis Drug Market Size Forecast by Region

12.1.1 Global Primary Biliary Cirrhosis Drug Forecast by Region (2023-2028)

12.1.2 Global Primary Biliary Cirrhosis Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Primary Biliary Cirrhosis Drug Forecast by Type

12.7 Global Primary Biliary Cirrhosis Drug Forecast by Application

13 Key Players Analysis

13.1 AlbireoPharma

13.1.1 AlbireoPharma Company Information

13.1.2 AlbireoPharma Primary Biliary Cirrhosis Drug Product Offered

13.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AlbireoPharma Main Business Overview

13.1.5 AlbireoPharma Latest Developments

13.2 CymaBay Therapeutics, Inc.

13.2.1 CymaBay Therapeutics, Inc. Company Information

13.2.2 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Offered

13.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CymaBay Therapeutics, Inc. Main Business Overview

13.2.5 CymaBay Therapeutics, Inc. Latest Developments

13.3 Dr. Falk Pharma GmbH

13.3.1 Dr. Falk Pharma GmbH Company Information

13.3.2 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Offered

13.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Dr. Falk Pharma GmbH Main Business Overview

13.3.5 Dr. Falk Pharma GmbH Latest Developments

13.4 Enanta Pharmaceuticals, Inc.

13.4.1 Enanta Pharmaceuticals, Inc. Company Information

13.4.2 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Offered

13.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Enanta Pharmaceuticals, Inc. Main Business Overview

13.4.5 Enanta Pharmaceuticals, Inc. Latest Developments

13.5 GlaxoSmithKline Plc

13.5.1 GlaxoSmithKline Plc Company Information

13.5.2 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Offered

13.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Plc Main Business Overview

13.5.5 GlaxoSmithKline Plc Latest Developments

13.6 Intercept Pharmaceuticals, Inc.

13.6.1 Intercept Pharmaceuticals, Inc. Company Information

13.6.2 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Offered

13.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Intercept Pharmaceuticals, Inc. Main Business Overview

13.6.5 Intercept Pharmaceuticals, Inc. Latest Developments

13.7 Johnson & Johnson

13.7.1 Johnson & Johnson Company Information

13.7.2 Johnson & Johnson Primary Biliary Cirrhosis Drug Product Offered

13.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Johnson & Johnson Main Business Overview

13.7.5 Johnson & Johnson Latest Developments

13.8 MediGene AG

13.8.1 MediGene AG Company Information

13.8.2 MediGene AG Primary Biliary Cirrhosis Drug Product Offered

13.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 MediGene AG Main Business Overview

13.8.5 MediGene AG Latest Developments

13.9 NGM Biopharmaceuticals, Inc.

13.9.1 NGM Biopharmaceuticals, Inc. Company Information

13.9.2 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Offered

13.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 NGM Biopharmaceuticals, Inc. Main Business Overview

13.9.5 NGM Biopharmaceuticals, Inc. Latest Developments

13.10 Virobay Inc.

13.10.1 Virobay Inc. Company Information

13.10.2 Virobay Inc. Primary Biliary Cirrhosis Drug Product Offered

13.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Virobay Inc. Main Business Overview

13.10.5 Virobay Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Primary Biliary Cirrhosis Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Primary Biliary Cirrhosis Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Budesonide

Table 4. Major Players of FFP-104

Table 5. Major Players of GSK-2330672

Table 6. Major Players of MBX-8025

Table 7. Major Players of NGM-282

Table 8. Major Players of Others

Table 9. Global Primary Biliary Cirrhosis Drug Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2022)

Table 11. Global Primary Biliary Cirrhosis Drug Revenue by Type (2017-2022) & ($ million)

Table 12. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Type (2017-2022)

Table 13. Global Primary Biliary Cirrhosis Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Primary Biliary Cirrhosis Drug Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2022)

Table 16. Global Primary Biliary Cirrhosis Drug Revenue by Application (2017-2022)

Table 17. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Application (2017-2022)

Table 18. Global Primary Biliary Cirrhosis Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Primary Biliary Cirrhosis Drug Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Primary Biliary Cirrhosis Drug Sales Market Share by Company (2020-2022)

Table 21. Global Primary Biliary Cirrhosis Drug Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2020-2022)

Table 23. Global Primary Biliary Cirrhosis Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Primary Biliary Cirrhosis Drug Producing Area Distribution and Sales Area

Table 25. Players Primary Biliary Cirrhosis Drug Products Offered

Table 26. Primary Biliary Cirrhosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Primary Biliary Cirrhosis Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Primary Biliary Cirrhosis Drug Sales Market Share Geographic Region (2017-2022)

Table 31. Global Primary Biliary Cirrhosis Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Primary Biliary Cirrhosis Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Primary Biliary Cirrhosis Drug Sales Market Share by Country/Region (2017-2022)

Table 35. Global Primary Biliary Cirrhosis Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Primary Biliary Cirrhosis Drug Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Primary Biliary Cirrhosis Drug Sales Market Share by Country (2017-2022)

Table 39. Americas Primary Biliary Cirrhosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2017-2022)

Table 41. Americas Primary Biliary Cirrhosis Drug Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2022)

Table 43. Americas Primary Biliary Cirrhosis Drug Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2022)

Table 45. APAC Primary Biliary Cirrhosis Drug Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Primary Biliary Cirrhosis Drug Sales Market Share by Region (2017-2022)

Table 47. APAC Primary Biliary Cirrhosis Drug Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Primary Biliary Cirrhosis Drug Revenue Market Share by Region (2017-2022)

Table 49. APAC Primary Biliary Cirrhosis Drug Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2022)

Table 51. APAC Primary Biliary Cirrhosis Drug Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2022)

Table 53. Europe Primary Biliary Cirrhosis Drug Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Country (2017-2022)

Table 55. Europe Primary Biliary Cirrhosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2017-2022)

Table 57. Europe Primary Biliary Cirrhosis Drug Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2022)

Table 59. Europe Primary Biliary Cirrhosis Drug Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Primary Biliary Cirrhosis Drug Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Primary Biliary Cirrhosis Drug Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Primary Biliary Cirrhosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Primary Biliary Cirrhosis Drug Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Primary Biliary Cirrhosis Drug Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Primary Biliary Cirrhosis Drug Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Primary Biliary Cirrhosis Drug

Table 70. Key Market Challenges & Risks of Primary Biliary Cirrhosis Drug

Table 71. Key Industry Trends of Primary Biliary Cirrhosis Drug

Table 72. Primary Biliary Cirrhosis Drug Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Primary Biliary Cirrhosis Drug Distributors List

Table 75. Primary Biliary Cirrhosis Drug Customer List

Table 76. Global Primary Biliary Cirrhosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Primary Biliary Cirrhosis Drug Sales Market Forecast by Region

Table 78. Global Primary Biliary Cirrhosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Primary Biliary Cirrhosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Primary Biliary Cirrhosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Primary Biliary Cirrhosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Primary Biliary Cirrhosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Primary Biliary Cirrhosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Primary Biliary Cirrhosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Primary Biliary Cirrhosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Primary Biliary Cirrhosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Primary Biliary Cirrhosis Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Primary Biliary Cirrhosis Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Primary Biliary Cirrhosis Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Primary Biliary Cirrhosis Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Application (2023-2028)

Table 96. AlbireoPharma Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. AlbireoPharma Primary Biliary Cirrhosis Drug Product Offered

Table 98. AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. AlbireoPharma Main Business

Table 100. AlbireoPharma Latest Developments

Table 101. CymaBay Therapeutics, Inc. Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Offered

Table 103. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. CymaBay Therapeutics, Inc. Main Business

Table 105. CymaBay Therapeutics, Inc. Latest Developments

Table 106. Dr. Falk Pharma GmbH Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Offered

Table 108. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Dr. Falk Pharma GmbH Main Business

Table 110. Dr. Falk Pharma GmbH Latest Developments

Table 111. Enanta Pharmaceuticals, Inc. Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 112. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Offered

Table 113. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Enanta Pharmaceuticals, Inc. Main Business

Table 115. Enanta Pharmaceuticals, Inc. Latest Developments

Table 116. GlaxoSmithKline Plc Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 117. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Offered

Table 118. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. GlaxoSmithKline Plc Main Business

Table 120. GlaxoSmithKline Plc Latest Developments

Table 121. Intercept Pharmaceuticals, Inc. Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 122. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Offered

Table 123. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Intercept Pharmaceuticals, Inc. Main Business

Table 125. Intercept Pharmaceuticals, Inc. Latest Developments

Table 126. Johnson & Johnson Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 127. Johnson & Johnson Primary Biliary Cirrhosis Drug Product Offered

Table 128. Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Johnson & Johnson Main Business

Table 130. Johnson & Johnson Latest Developments

Table 131. MediGene AG Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 132. MediGene AG Primary Biliary Cirrhosis Drug Product Offered

Table 133. MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. MediGene AG Main Business

Table 135. MediGene AG Latest Developments

Table 136. NGM Biopharmaceuticals, Inc. Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 137. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Offered

Table 138. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. NGM Biopharmaceuticals, Inc. Main Business

Table 140. NGM Biopharmaceuticals, Inc. Latest Developments

Table 141. Virobay Inc. Basic Information, Primary Biliary Cirrhosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 142. Virobay Inc. Primary Biliary Cirrhosis Drug Product Offered

Table 143. Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Virobay Inc. Main Business

Table 145. Virobay Inc. Latest Developments

List of Figures

Figure 1. Picture of Primary Biliary Cirrhosis Drug

Figure 2. Primary Biliary Cirrhosis Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Primary Biliary Cirrhosis Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Primary Biliary Cirrhosis Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Primary Biliary Cirrhosis Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Budesonide

Figure 10. Product Picture of FFP-104

Figure 11. Product Picture of GSK-2330672

Figure 12. Product Picture of MBX-8025

Figure 13. Product Picture of NGM-282

Figure 14. Product Picture of Others

Figure 15. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type in 2021

Figure 16. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Type (2017-2022)

Figure 17. Primary Biliary Cirrhosis Drug Consumed in Clinic

Figure 18. Global Primary Biliary Cirrhosis Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 19. Primary Biliary Cirrhosis Drug Consumed in Hospital

Figure 20. Global Primary Biliary Cirrhosis Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 21. Primary Biliary Cirrhosis Drug Consumed in Others

Figure 22. Global Primary Biliary Cirrhosis Drug Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Application in 2021

Figure 25. Primary Biliary Cirrhosis Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Company in 2021

Figure 27. Global Primary Biliary Cirrhosis Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Primary Biliary Cirrhosis Drug Sales 2017-2022 (K Pcs)

Figure 32. Americas Primary Biliary Cirrhosis Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Primary Biliary Cirrhosis Drug Sales 2017-2022 (K Pcs)

Figure 34. APAC Primary Biliary Cirrhosis Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Primary Biliary Cirrhosis Drug Sales 2017-2022 (K Pcs)

Figure 36. Europe Primary Biliary Cirrhosis Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Primary Biliary Cirrhosis Drug Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Primary Biliary Cirrhosis Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2021

Figure 40. Americas Primary Biliary Cirrhosis Drug Revenue Market Share by Country in 2021

Figure 41. United States Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Primary Biliary Cirrhosis Drug Sales Market Share by Region in 2021

Figure 46. APAC Primary Biliary Cirrhosis Drug Revenue Market Share by Regions in 2021

Figure 47. China Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2021

Figure 54. Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Country in 2021

Figure 55. Germany Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Primary Biliary Cirrhosis Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Primary Biliary Cirrhosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug in 2021

Figure 68. Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

Figure 69. Industry Chain Structure of Primary Biliary Cirrhosis Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles